domingo, 21 de junio de 2020

Renin-Angiotensin-Aldosterone Inhibitors and Susceptibility to and Severity of COVID-19 G Kurfman, JAMA, June 19, 2020

Hot Topics of the Day|PHGKB

Coronavirus

A new study together with previous studies in other patient populations, should lay to rest concerns about the use of ACEI/ARBs in patients with or at risk for COVID-19. When there is a clinical indication for their use, ACEI/ARBs should not be discontinued in patients with COVID-19, unless the drugs cannot be tolerated due to hemodynamic instability.
Epidemiological models suggest apps can change a pandemic's course. Ensuring that an app detects risky contacts without overwhelming users with false alarms is one challenge; getting enough people to download an app is another. Health officials weigh competing apps and prepare pitches to privacy-conscious citizens considering how to put an app to the test.
Exosomal microRNAs Drive Thrombosis in COVID-19
J Gambardella et al, MEDRXIV, June 18, 2020

No hay comentarios:

Publicar un comentario